SCHEMBL7874547

SCHEMBL7874547

CCNC(=O)c1cccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCO)nc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
P4HTM Q9NXG6 3/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39
CYP2C19 P33261 1/20 0.39
GABRA5 P31644 4/20 0.38
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
LOX P28300 1/20 0.38
CASP3 P42574 1/20 0.38
EGFR P00533 1/20 0.38
HDAC2 Q92769 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867848 0.92 SMN1; SMN2 (0.45) SMN1; SMN2HSD17B10P4HTMMEN1KMT2A
SCHEMBL7871660 0.92 SMN1; SMN2 (0.42) SMN1; SMN2OPRM1OPRD1OPRK1P4HTM
SCHEMBL7862681 0.91 HSD17B10 (0.43) SMN1; SMN2HSD17B10P4HTMMEN1KMT2A
SCHEMBL7869413 0.90 SMPD1 (0.45) SMN1; SMN2HSD17B10KMT2AGABRA5
SCHEMBL7870447 0.90 HSD17B10 (0.41) SMN1; SMN2HSD17B10P4HTMMEN1KMT2A
SCHEMBL7871681 0.89 EGFR (0.46) OPRM1OPRD1OPRK1P4HTMGABRA5
SCHEMBL7869480 0.89 HSD17B10 (0.42) SMN1; SMN2HSD17B10P4HTMMEN1KMT2A
SCHEMBL7862782 0.88 RAB9A (0.49) SMN1; SMN2HSD17B10P4HTMMEN1KMT2A
SCHEMBL7871628 0.88 HTT (0.53) HSD17B10P4HTMLMNAHTTHDAC2
SCHEMBL7870551 0.87 RAB9A (0.49) SMN1; SMN2HSD17B10P4HTMBCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed